Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Nuvation Bio Inc. (NUVB) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Nuvation Bio Inc. (NUVB), most recent 12 months reported: revenue $169.9M, net loss $149.83M, free cash flow -$128.93M. Latest balance sheet on file: liquid cash $660.96M. From SEC filings. Others in Pharmaceutical Preparations: CRYOPORT, INC. · AMARIN CORP PLC\UK · LIFEVANTAGE CORP · Arbutus Biopharma Corp · MACROGENICS, INC. · HERON THERAPEUTICS, INC. /DE/ · Karyopharm Therapeutics Inc. · Elite Pharmaceuticals, Inc.

Stock screener

Watchlist